Social Media Implications, Solidifying Data for On-Site Presentation Among Key Topics
(Chicago, IL) – Regulatory professionals now have the opportunity to obtain the most pertinent information on FDA Advisory Committee meetings from first-hand experiences of industry leaders. The FDA Advisory Committee Meeting Strategies Conference will take place September 11-12 in Alexandria, Virginia, with in-depth sessions led by experts from small, medium and large pharmaceutical companies and medical groups.
Nearly two dozen regulatory professionals will be on hand to present sessions, panel discussions and case studies to attendees, including Andrew Storey of Abbvie, Ayse Baker of Sanofi, and Michael Nelson of the US Army. Topics being discussed address all facets of FDA Advisory Committee meetings, such as creating structured timelines for preparation processes, efficient composition methods for briefing books, the implications of social media usage post-meeting and employing production decision-making tactics without FDA guidance. Speakers at the conference have all participated in an FDA Advisory Committee meeting, providing first-hand knowledge and experience to conference attendees.
In addition to several networking opportunities throughout the two-day conference, attendees will participate in workshops that offer an opportunity to share ideas with fellow regulatory professionals. Mock scenarios will be conducted focusing on overcoming unforeseen complications before and during advisory committee meetings, and participants will learn the best practices for executing meetings through small group collaboration. Small group breakout discussions are also scheduled, and will provide a forum for networking and idea sharing on topics that are of utmost concern to regulatory professionals.
For more information or to register for the FDA Advisory Committee Meeting Strategies Conference, please visit www.q1productions.com/adcom.
